The serum thyroid stimulating hormone (TSH) 
Introduction

Acromegalic patients frequently have associated thyroid disorders. In particular, non-toxic nodular or diffuse goiter and toxic nodular goiter are often observed (1). In addition, thyroid volume and vascularity are also increased in acromegaly (2, 3). These findings may suggest that in acromegalic patients growth hormone (GH) and/or insulin-like growth factor-I (IGF-I) have growth promotive effects on the thyroid. On the other hand, acromegaly rarely complicates autoimmune thyroid diseases such as Graves' disease or Hashimoto's thyroiditis. It is commonly known that the serum thyroid stimulating hormone (TSH) level is decreased in acromegalic patients. The response of TSH to TSH releasing hormone (TRH) is lower in acromegaly than in prolactinoma
. A previous report stated that acromegalic patients show low concentrations of TSH, free T4 and T4 compared with the control group, indicating central hypothyroidism (5) 
Case Report
A (Fig. 1) . Thyroid hormone levels in the clinical course were within the normal limit; therefore, anti-thyroid drug has not been prescribed to the present (Fig. 1) 
F i g u r e 1 . Cl i n i c a l c o u r s e o f T S H a n d f r e e T 4 l e v e l s . Cl o s e d c i r c l e s me a n T S H a n d c l o s e d s q u a r e s me a n f r e e T 4 . T h e d a y wh e n t h e o p e r a t i o n wa s p e r f o r me d i s i n d i c a t e d b y t h e a r r o w.
Discussion
Falaschi et al presented the equations obtained by multiple regression analysis between freeT3, freeT4 and TSH values, in normal subjects and in patients with subclinical hyper and hypothyroidism (9). Present patient's data was in relative agreement with their data, when applied to the equation of hyperthyroidism (hyperthyroidism: TSH=0.42-0.08× freeT4-0.03×freeT3). In contrast to the equation of hyperthyroidism, the equation of hypothyroidism did not match
